# Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)

> **NCT00119457** · PHASE2 · COMPLETED · sponsor: **vTv Therapeutics** · enrollment: 300 (—)

## Conditions studied

- Venous Thromboembolism
- Embolism and Thrombosis
- Hip Fractures

## Interventions

- **DRUG:** TTP889

## Key facts

- **NCT ID:** NCT00119457
- **Lead sponsor:** vTv Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 300 (—)
- **Last updated:** 2009-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00119457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00119457, "Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00119457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*